Clinical Trial Update: Study To Evaluate Safety And Tolerability Of GSK256066 In Chronic Obstructive Pulmonary Disease (COPD) Patients [Phase 2]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 2 study evaluating the safety and tolerability of the inhaled compound GSK256066 in patients with c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• GSK256066

Snippet

Sponsor: GlaxoSmithKline | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 2 | Status: COMPLETED